Viking Therapeutics, Inc.
VKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001607678
In the last 90 days, Viking Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 437 institutions reported holding it in 13F filings for Q2 2026, worth $2.96B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Viking Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 392
- +23 vs. Q1 2025
- Shares held
- 76.2M
- −1.52M (−2.0%) vs. Q1 2025
- Total value
- $2.02B
- +$141.9M (+7.6%) vs. Q1 2025
- New holders
- 82
- 149 more added
- Sold out
- 59
- 109 more reduced
4 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 437 | $2.96B |
| Q1 2026 | 414 | $2.43B |
| Q4 2025 | 427 | $2.54B |
| Q3 2025 | 371 | $1.87B |
| Q2 2025 | 392 | $2.02B |
| Q1 2025 | 373 | $1.88B |
| Q4 2024 | 409 | $3.30B |
| Q3 2024 | 422 | $5.27B |
| Q2 2024 | 388 | $4.26B |
| Q1 2024 | 373 | $6.56B |
| Q4 2023 | 197 | $1.42B |
| Q3 2023 | 179 | $854.0M |
| Q2 2023 | 193 | $1.21B |
| Q1 2023 | 185 | $1.11B |
| Q4 2022 | 129 | $319.7M |
| Q3 2022 | 107 | $72.4M |
| Q2 2022 | 115 | $77.2M |
| Q1 2022 | 140 | $93.8M |
| Q4 2021 | 140 | $166.5M |
| Q3 2021 | 135 | $237.7M |
| Q2 2021 | 138 | $226.9M |
| Q1 2021 | 144 | $259.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Viking Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Portolan Capital Management, LLC | 0 | $0 | 0.00% | −138,748−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −83,270−100.0% | Sold out |
| Financial Counselors Inc | 0 | $0 | 0.00% | −55,476−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −52,467−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −51,400−100.0% | Sold out |
| Aptus Capital Advisors, LLC | 0 | $0 | 0.00% | −50,381−100.0% | Sold out |
| Second Line Capital, LLC | 0 | $0 | 0.00% | −50,381−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −27,911−100.0% | Sold out |
| Mediolanum International Funds Ltd | 0 | $0 | 0.00% | −25,258−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −24,500−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −16,458−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −18,748−100.0% | Sold out |
| Silvant Capital Management LLC | 0 | $0 | 0.00% | −17,231−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −14,470−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,350−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −13,780−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −11,806−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −11,485−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −11,115−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −10,502−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −10,393−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −6,085−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −10,003−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −9,533−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −8,327−100.0% | Sold out |
| Runnymede Capital Advisors, Inc. | 0 | $0 | 0.00% | −5,990−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −4,083−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −3,043−100.0% | Sold out |
| JNBA Financial Advisors | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Flaharty Asset Management, LLC | 0 | $0 | 0.00% | −2,299−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −1,887−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −1,699−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,638−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,292−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,205−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −558−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Trivant Custom Portfolio Group, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Caas Capital Management LP | – | – | – | – | Not filed |
| Cahill Wealth Management, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |